MECP2 and autoimmune thyroid disease: (23) reported thyroid disorders in approximately 10% of 51 RTT patients, ranging from autoimmune thyroiditis to central hypothyroidism and hyperthyreotropinemia, with MeCP2 mutations being the most frequent genotype.